Pulmonary-delivered insulin: Partner Pfizer began a Phase II trial

Inhale Therapeutic Systems (INHL), Palo Alto, Calif. Product: Pulmonary-delivered insulin Indication: Diabetes Status: Partner Pfizer began a Phase II trial of INHL's system in 10-20 diabetics. The p...